Alkermes is building on its neuroscience heritage to fuel R&D progress


Neurological and psychiatric diseases strike at the core of who we are as people, often irreversibly impacting many facets of life for affected individuals and those around them. While remarkable progress has been made in our understanding of and ability to treat these disorders over the last several decades, neurological or central nervous system (CNS) disorders remain the leading cause of disability and the second leading cause of death worldwide.

Globally, the numbers of deaths and people with…

Previous PreventScripts raises more than $1 million, looks to speed up growth
Next Legend Senior Living 'sets the stage for the next generation of growth'